• Explore /
  • Poster
  • / Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial.

Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial.

Abstract Poster

Authors

null

Somnath Mukherjee

University of Oxford, Oxford, United Kingdom

Somnath Mukherjee , Chris Hurt , Catrin Cox , Ganesh Radhakrishna , Sarah Gwynne , Andrew Rea Bateman , Simon Gollins , Maria A. Hawkins , Jo Canham , Heike I. Grabsch , Stephen Falk , Ricky A. Sharma , Ruby Ray , Rajarshi Roy , Wendy Wade , Rhydian Maggs , David joseph sebag-Montefiore , Tim Maughan , Gareth Owen Griffiths , Tom David Lewis Crosby

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT01843829

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 373)

Abstract #

373

Poster Bd #

E6

Abstract Disclosures

Similar Posters

First Author: Somnath Mukherjee

First Author: Thomas Crosby

First Author: Geoffrey Yuyat Ku

First Author: Darren Cowzer